Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Otolaryngologia Polska = the Polish Otolaryngology|April 17, 2012
Molecular pathogenesis of vestibular schwannomas: insights for the development of novel medical therapiesCraig Miller, Suzu Igarashi, Abraham JacobPlant Disease|February 21, 2019
Host Resistance to Monilinia vaccinii-corymbosi in Flowers and Fruits of Highbush BlueberryJeffrey S Lehman, Suzu Igarashi, Peter V OudemansThe Annals of Otology, Rhinology, and Laryngology|May 29, 2015
The Solid Component of Radiographically Non-Growing, Post-Radiated Vestibular Schwannoma Retains Proliferative Capacity: Implications for Patient CounselingAbraham Jacob, Suzu Igarashi, Terry Platto, et al.Gastroenterology|April 29, 2008
Sp1 is required for glucose-induced transcriptional regulation of mouse vesicular glutamate transporter 2 geneTao Li, Liqun Bai, Jing Li, et al.Mbio|July 26, 2018
Virus Control of Trafficking from Sorting EndosomesSebastian Zeltzer, Carol A Zeltzer, Suzu Igarashi, et al.Plos Pathogens|November 15, 2019
Host signaling and EGR1 transcriptional control of human cytomegalovirus replication and latencyJason Buehler, Ethan Carpenter, Sebastian Zeltzer, et al.Proceedings of the National Academy of Sciences of the United States of America|August 15, 2019
Alternative promoters drive human cytomegalovirus reactivation from latencyDonna Collins-McMillen, Mike Rak, Jason C Buehler, et al.Proceedings of the National Academy of Sciences of the United States of America|July 23, 2020
FOXO transcription factors activate alternative major immediate early promoters to induce human cytomegalovirus reactivationAndrew E Hale, Donna Collins-McMillen, Erik M Lenarcic, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|June 2, 2015
Zebrafish swimming behavior as a biomarker for ototoxicity-induced hair cell damage: a high-throughput drug development platform targeting hearing lossMaki Niihori, Terry Platto, Suzu Igarashi, et al.Investigational New Drugs|November 27, 2012
Characterization of a membrane-active anti-tumor agent, UA8967Robert T Dorr, Betty K Samulitis, Lee Wisner, et al.Pageof 2